Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine versus bupivacaine for cognitive function after elective cataract surgery
PACTR201806003395974Not yet recruiting
- Sponsor
- Beni Suef University
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of lidocaine and bupivacaine in cataract (2 arms), sponsored by Beni Suef University. Primary endpoint: cognitive dysfunction. Planned start May 2018; status: not yet recruiting.
02
Drugs
lidocainebupivacaine
03
Conditions
cataract
Beyond the preview
Go deeper on PACTR201806003395974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201806003395974.